𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infection

✍ Scribed by Guarascio, Paolo; De Felici, Anna Paola; Migliorini, Daniela; Alexander, Graeme J.M.; Fagan, Elizabeth A.; Visco, Giuseppe


Book ID
122395097
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
297 KB
Volume
3
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Controlled clinical trial of acyclovir i
✍ Dr. Graeme J. M. Alexander; Elizabeth A. Fagan; John E. Hegarty; Adrian L. W. F. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 470 KB πŸ‘ 1 views

A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi

Impaired interferon induction of human M
✍ FernΓ‘ndez, Mario; Quiroga, Juan Antonio; MartΓ­n, Julio; Cotonat, Teresa; Pardo, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 215 KB πŸ‘ 2 views

MxA protein is interferon inducible, and its role as an antiviral mediator is being studied in various viral diseases. Several cytokines, including type I interferons (␣ and ␀), interleukins 2 and 12, and granulocyte, macrophage, and granulocyte-macrophage colony-stimulating factors, were tested for